A promising new discovery from the Hebrew University of Jerusalem reveals that cross-linked hyaluronic acid (XHA) significantly enhances the retention and concentration of topical antibiotics in the tear film of dogs. Compared to traditional formulations using polyvinyl alcohol (PVA), the XHA-based eyedrops maintained higher drug levels for longer durations. This innovation not only suggests improved treatment outcomes for veterinary patients – it also carries meaningful implications for human medicine.

CapsiBreed, an AgriTech startup, has signed a landmark commercial agreement with Dutch seed company Erma Zaden to apply its proprietary technology for gene-editing elite pepper varieties. This first-of-its-kind partnership positions CapsiBreed for rapid market entry, enabling precise enhancement of high-value traits such as shelf life, flavor, yield, and disease resistance. The deal marks a significant commercial validation of CapsiBreed’s platform and services, and a major step toward scalable, sustainable agricultural innovation.

A new study from the Hebrew University of Jerusalem reveals that bacterial movement plays a central role in the transfer of antibiotic resistance genes. The research team discovered that the rotation of flagella in Bacillus subtilis acts as a mechanical signal that activates key conjugation genes. This enables donor bacteria to form clusters with recipients and successfully transfer DNA in liquid environments. The findings suggest that bacteria can use motion to control when and where gene sharing occurs, offering new insight into the spread of resistance across species.

Jerusalem, April 6, 2025 – In celebration of the Hebrew University of Jerusalem’s centennial, the University’s senior leadership and prominent alumni opened trading this morning at the Tel Aviv Stock Exchange (TASE), underscoring a century of academic excellence and impactful contributions to Israel’s economy and society.

March 25, 2025 – AFHU joins the Hebrew University of Jerusalem in congratulating Prof. Yinon Ben-Neriah on being awarded the prestigious Israel Prize for his groundbreaking contributions to cancer research.

A new study led by Dr. Hilla Chen from the Koret School of Veterinary Medicine at Hebrew University, recently published in Journal of Veterinary Internal Medicine, offers new hope for the management of chronic kidney disease (CKD) in dogs. The research highlights the potential benefits of paricalcitol, a second-generation vitamin D analog, in addressing renal secondary hyperparathyroidism (RHPT) and proteinuria—two critical complications of CKD.

The Hebrew University of Jerusalem proudly extends its heartfelt congratulations to Prof. Yinon Ben-Neriah of the Faculty of Medicine on being awarded the prestigious Israel Prize for his groundbreaking contributions to cancer research.

We extend our heartfelt congratulations to Hebrew University alumni Assaf Rappaport, Ami Lotbek, and Yinon Costica on achieving the largest exit in Israel’s history with the acquisition of WIZ by Google!

Rappaport, Lotbek, and Costica are all proud graduates of the Hebrew University, with Lotbek also holding a master’s degree from the School of Engineering and Computer Science. We take immense pride in your achievement.